Combine searches by placing the search numbers in the top search box and pressing the search button. An example search might look like (#1 or #2) and (#3 or #4)
Latest & greatest articles for Tongue Carcinoma
The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on Tongue Carcinoma or other clinical topics then use Trip today.
This page lists the very latest high quality evidence on Tongue Carcinoma and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.
What is Trip?
Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.
Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.
As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.
For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via email@example.com
Prognostic value of tumor microenvironment biomarkers in oral tongue squamous cell carcinoma (OTSCC): a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any
Squamous-Cell Carcinoma of the Tongue. 27332922 2016 07 13 2016 06 23 1533-4406 374 25 2016 Jun 23 The New England journal of medicine N. Engl. J. Med. IMAGES IN CLINICAL MEDICINE. Squamous-Cell Carcinoma of the Tongue. e32 10.1056/NEJMicm1513456 Albuquerque Rui P P RP University of Birmingham, Birmingham, United Kingdom firstname.lastname@example.org. Richards Andrea A University of Birmingham, Birmingham, United Kingdom email@example.com. eng Case Reports Journal Article United (...) States N Engl J Med 0255562 0028-4793 AIM IM Aged Biopsy Carcinoma, Squamous Cell pathology Female Humans Tongue pathology Tongue Neoplasms pathology 2016 6 23 6 0 2016 6 23 6 0 2016 7 14 6 0 ppublish 27332922 10.1056/NEJMicm1513456
Preliminary Results Suggest miR-139-5p Is a Viable Salivary Biomarker for Diagnosis of Tongue Squamous Cell Carcinoma (TSCC) UTCAT3049, Found CAT view, CRITICALLY APPRAISED TOPICs University: | | ORAL HEALTH EVIDENCE-BASED PRACTICE PROGRAM View the CAT / Title Preliminary Results Suggest miR-139-5p Is a Viable Salivary Biomarker for Diagnosis of Tongue Squamous Cell Carcinoma (TSCC) Clinical Question In patients with undiagnosed tongue squamous cell carcinoma, can a salivary test conducted (...) in the dental office effectively detect tongue squamous cell carcinoma through the identification of a microRNA biomarker? Clinical Bottom Line The cohort study conducted by Duz et. al. concludes that miR-139-5p is a feasible salivary biomarker for detection of tongue squamous cell carcinoma (TSCC). This study found that expression levels of miR-139-5p in saliva of TSCC patients were significantly decreased compared to control samples. With future studies validating sensitivity and specificity, salivary